kabutan

Kohjin Bio Co.,Ltd.(177A) Summary

177A
TSE Growth
Kohjin Bio Co.,Ltd.
1,430
JPY
+86
(+6.40%)
Apr 28, 3:30 pm JST
8.98
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
21.8
PBR
1.24
Yield
0.70%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:57 am
1,330 JPY 8.34 USD
Previous Close Apr 27
1,344 JPY 8.43 USD
High Apr 28, 2:04 pm
1,433 JPY 9.00 USD
Low Apr 28, 9:57 am
1,330 JPY 8.33 USD
Volume
14,700
Trading Value
0.02B JPY 0.13M USD
VWAP
1395.06 JPY 8.76 USD
Minimum Trading Value
143,000 JPY 898 USD
Market Cap
7.31B JPY 0.05B USD
Number of Trades
64
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly Low
1-Year Average
49
1-Year High Aug 27, 2025
1,762
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 173,300
Apr 17, 2026 0 169,000
Apr 10, 2026 0 131,300
Apr 3, 2026 0 121,300
Mar 27, 2026 0 119,200
Company Profile
Kohjin Bio Co., Ltd. specializes in the development, manufacturing, and sales of cell culture media, as well as contract manufacturing of cell-processed products.
Sector
Chemicals
Kohjin Bio Co., Ltd. primarily focuses on the manufacturing and sales of bacterial culture media, in vitro diagnostic pharmaceuticals, and cell culture media, while also emphasizing regenerative medicine. The company particularly concentrates on developing and selling serum-free media, providing culture media for stem cells and immune cells. Additionally, they manufacture and sell antigen test kits for COVID-19 and influenza. In their cell processing business, Kohjin Bio manufactures specific cell-processed products commissioned by medical institutions and offers regulatory compliance support for regenerative medicine. Working in collaboration with domestic and international group companies, Kohjin Bio provides a wide range of products and services related to microbial testing and regenerative medicine.